Injective’s Buyback Removes 7.27 Million INJ From Circulation
TronWeekly reports that Injective’s buyback program has retired more than 7.27 million INJ tokens, while the asset trades below key technical levels.
TronWeekly reports that Injective’s buyback program has retired more than 7.27 million INJ tokens, while the asset trades below key technical levels. Injective (INJ) is trading at ₹736 ($7.83), down 0.4% since this brief published. This is an original Token Times brief based on reporting by TronWeekly, with live market data added, as of Wed, 11 Nov 2026 22:00:01 UTC.
By removing tokens from circulation, the buyback changes INJ’s available supply and gives the project’s token economics a direct market mechanism. The size of the program relative to INJ’s $786.47 million market capitalization makes continued repurchases relevant to future supply and liquidity conditions.
- Injective has removed more than 7.27 million INJ from circulation.
- The program is valued at roughly $58 million by TronWeekly.
- INJ trades at $7.86, down 2.01% over 24 hours.
- Attention remains on $8.29 and $8.60 resistance levels.
Injective’s token buyback has retired more than 7.27 million INJ from circulation, according to TronWeekly. The outlet values the repurchased tokens at approximately $58 million as of October 22, 2026; the supplied headline places the program at $57.5 million, reflecting a minor difference in how the same total is presented.
The development introduces a recurring demand mechanism for INJ: tokens purchased through the strategy are taken out of the circulating supply rather than remaining available for trading. TronWeekly’s $58 million figure puts the program at roughly 7.5% of Injective’s current $786.47 million market capitalization, based on the supplied live data.
INJ is trading at $7.86, down 2.01% over 24 hours but up 0.50% over seven days. TronWeekly identified $8.29 and $8.60 as resistance levels, while analyst ZAYK Charts set a conditional long-term breakout target of $50. These are technical reference points rather than evidence that either price threshold has been reached.
The broader crypto market capitalization stands at $2.54 trillion and is described as flat, while 
Bitcoin is up 0.91% over 24 hours. The Fear & Greed index is at 29, indicating a Fear reading. Continued buyback activity, INJ’s ability to reclaim the cited resistance levels and changes in the broader sentiment reading are the main factors to monitor.
Since this brief published about 2 hours ago, Injective (INJ) has moved from ₹738.49$7.86 to ₹735.67$7.83 — -0.38%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₹778.03 (about $7.83), down 3.3% over 24 hours. The rupee itself trades about 5.8% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Injective’s Buyback Removes 7.27 Million INJ From Circulatio — questions & answers
How many INJ tokens have been repurchased?
TronWeekly reports that Injective’s buyback strategy has removed more than 7.27 million INJ from circulation.
What is the reported value of the buyback program?
The program is valued at approximately $58 million as of October 22, 2026, while the supplied headline lists $57.5 million.
Where is INJ trading and what levels matter?
INJ is trading at $7.86. TronWeekly identifies $8.29 and $8.60 as resistance levels.
How much is 1 Injective worth in rupee today?
About ₹778.03 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $7.83. The rupee price moves with both INJ's US-dollar price and the USDT/INR rate; use our Injective in rupee page for any amount.
Has Injective's price moved since this brief was published?
INJ is down 0.38% since this brief first published — trading at ₹736 ($7.83) now versus ₹738 ($7.86) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from TronWeekly. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.